Literature DB >> 11440409

Blood-borne infections in Dublin's opiate users.

M Fitzgerald1, J Barry, P O'Sullivan, L Thornton.   

Abstract

BACKGROUND: Injecting drug users are at high risk of acquiring blood-borne infections. Ireland has had a harm reduction policy of methadone maintenance and needle exchange since 1992. AIM: To estimate prevalence of hepatitis B, hepatitis C and HIV infection and appropriate uptake of hepatitis B vaccine in methadone attendees and to make recommendations for a simple record-based surveillance system.
METHOD: Retrospective study of 138 client records for evidence of laboratory tests or test results for blood-borne viruses and appropriate immunisation against hepatitis B.
RESULTS: A total of 60% of clients had evidence of one or more laboratory tests in their notes. Of those tested for individual viruses, 5.1% were positive for hepatitis B surface antigen, 78.8% had antibodies to hepatitis C and 16.7% were HIV positive. Nearly two-thirds of clients had no evidence of vaccination or information on prior immunity in their records.
CONCLUSIONS: A standardised written protocol for screening for blood-borne viruses and for immunisation against hepatitis B in methadone service attendees was clearly needed, and was subsequently introduced by the Eastern Region Health Authority.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440409     DOI: 10.1007/BF03167717

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   2.089


  10 in total

1.  Evaluation of the impact of Dublin's expanded harm reduction programme on prevalence of hepatitis C among short-term injecting drug users.

Authors:  B P Smyth; E Keenan; J J O'Connor
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

2.  Young injectors: a comparative analysis of risk behaviour.

Authors:  S Cassin; T Geoghegan; G Cox
Journal:  Ir J Med Sci       Date:  1998 Oct-Dec       Impact factor: 1.568

3.  HIV risk behaviour in Irish intravenous drug users.

Authors:  A Dorman; E Keenan; C Schuttler; J Merry; J J O'Connor
Journal:  Ir J Med Sci       Date:  1997 Oct-Dec       Impact factor: 1.568

4.  The HIV epidemic in injecting drug users.

Authors:  P B Madden; T Lamagni; V Hope; D Bennett; D Goldberg
Journal:  Commun Dis Rep CDR Rev       Date:  1997-08-22

5.  Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.

Authors:  K Stark; R Müller; U Bienzle; I Guggenmoos-Holzmann
Journal:  AIDS       Date:  1996-03       Impact factor: 4.177

6.  The opiate epidemic in Dublin 1979-1983.

Authors:  G Dean; A O'Hare; A O'Connor; M Kelly; G Kelly
Journal:  Ir Med J       Date:  1985-04

7.  Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995.

Authors:  N Crofts; C K Aitken
Journal:  Med J Aust       Date:  1997-07-07       Impact factor: 7.738

8.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.

Authors:  S Allwright; F Bradley; J Long; J Barry; L Thornton; J V Parry
Journal:  BMJ       Date:  2000-07-08

9.  Prevalence of antibiotics to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992.

Authors:  F Bolumar; I Hernandez-Aguado; L Ferrer; I Ruiz; M J Aviño; M Rebagliato
Journal:  Int J Epidemiol       Date:  1996-02       Impact factor: 7.196

10.  Guidelines for designing rapid assessment surveys of HIV seroprevalence among hospitalized patients. Centers for Disease Control and Prevention.

Authors:  B Schwartländer; R S Janssen; G A Satten; S E Critchley; L R Petersen; T J Dondero
Journal:  Public Health Rep       Date:  1994 Jan-Feb       Impact factor: 2.792

  10 in total
  6 in total

1.  Guidelines for the management of hepatitis C in general practice: a semi-qualitative interview survey of GPs' views regarding content and implementation.

Authors:  W Cullen; M O'Leary; D Langton; J Stanley; Y Kelly; G Bury
Journal:  Ir J Med Sci       Date:  2005 Jul-Sep       Impact factor: 1.568

2.  Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.

Authors:  L Grogan; M Tiernan; N Geogeghan; B Smyth; E Keenan
Journal:  Ir J Med Sci       Date:  2005 Apr-Jun       Impact factor: 1.568

3.  Hepatitis C infection among drug users attending general practice.

Authors:  W Cullen; G Bury; J Barry; F D O'Kelly
Journal:  Ir J Med Sci       Date:  2003 Jul-Sep       Impact factor: 1.568

4.  Patients in long-term maintenance therapy for drug use in Italy: analysis of some parameters of social integration and serological status for infectious diseases in a cohort of 1091 patients.

Authors:  Gianluca Quaglio; Fabio Lugoboni; Cristian Pattaro; Linda Montanari; Alessandro Lechi; Paolo Mezzelani; Don C Des Jarlais
Journal:  BMC Public Health       Date:  2006-08-23       Impact factor: 3.295

Review 5.  Hepatitis C virus infection in Irish drug users and prisoners - a scoping review.

Authors:  D Crowley; R Murtagh; W Cullen; J S Lambert; T McHugh; M C Van Hout
Journal:  BMC Infect Dis       Date:  2019-08-08       Impact factor: 3.090

6.  Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care.

Authors:  Eithne Nic An Riogh; Davina Swan; Geoff McCombe; Eileen O'Connor; Gordana Avramovic; Juan Macías; Cristiana Oprea; Alistair Story; Julian Surey; Peter Vickerman; Zoe Ward; John S Lambert; Willard Tinago; Irina Ianache; Maria Iglesias; Walter Cullen
Journal:  J Antimicrob Chemother       Date:  2019-11-01       Impact factor: 5.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.